| Literature DB >> 27843365 |
Koji J Duncan1, Jaclyn N Chopp-Hurley1, Monica R Maly1.
Abstract
PURPOSE: Among a variety of conservative and surgical options to treat anterior cruciate ligament (ACL) injuries, we do not understand which options could potentially prevent knee osteoarthritis (OA). The aim of this systematic review was to examine the evidence pertaining to exercise treatment of ACL injuries in the context of knee OA.Entities:
Keywords: articular; exercise therapy; knee; ligament; osteoarthrosis; rehabilitation
Year: 2016 PMID: 27843365 PMCID: PMC5098766 DOI: 10.2147/OARRR.S81673
Source DB: PubMed Journal: Open Access Rheumatol ISSN: 1179-156X
Search strategy; 68 key words within four key terms (knee, osteoarthritis, anterior cruciate ligament, exercise)
| Knee (5) | Osteoarthritis (11) | Anterior cruciate ligament (4) | |
|---|---|---|---|
| 1. Knee | 1. | 1. Anterior cruciate ligament | |
| 1. Exercises | 13. Aerobic exercises | 25. Static stretching | 37. Weight-bearing strengthening program |
Note:
The search term was specifically “osteoarthrit*” not osteoarthritis. This ensured that words such as osteoarthritic were also searched.
Summary of studies included in review
| Author (year); PEDro scale score | Sample information; length of follow-up; retention | Intervention; retention | Results summary |
|---|---|---|---|
| Giove et al | Sample: n=24 | Intervention: | 1. Radiographic (n=22; two patients refused radiographs) |
| Hawkins et al | Sample: n=40 | Intervention: | 1. Radiographic |
| Kannus and Jarvinen | Sample: n=98 | Intervention: | 1. Radiographic |
| Pattee et al | Sample: n=68 | Intervention: | 1. Radiographic (n=20/31) |
| Daniel et al | Sample: n=298 | Intervention: | 208 knees underwent arthroscopy to verify tears; n=2 (1%) of unstable and n=9 (50%) of stable knees did not have tears |
| Fink et al | Sample: n=113 | Intervention: | 1. Radiographic |
| Fithian et al | Sample: n=287 | Intervention: | Low risk group had fewer later surgeries (16%) than moderate and high risk groups, collectively (33%; |
| Meunier et al | Sample: n=100 | Intervention: | Meniscus injury prevalence lower in the operative group (12%) compared to exercise group (35%) ( |
| Kostogiannis et al | Sample: n=100 | Intervention: | No differences between patients who underwent self-monitored or supervised rehabilitation |
| Neuman et al | Sample: n=100 | Intervention: | 1. Radiographic |
| Neuman et al | Sample: n=100 | Intervention: | Radiographic results described in Neuman et al. |
| Kessler et al | Sample: n=109 | Intervention: | 1. Radiographic |
| Meuffels et al | Sample: n=50 | Intervention: | 68% of operative and 80% of exercise group had meniscal surgery by 10 y FU ( |
| Mihelic et al | Sample: n=54 | Intervention: | 1. Radiographic |
| Streich et al | Sample: n=126 | Intervention: | Significantly higher rate of meniscal surgery in exercise group than operative group ( |
| Potter et al | Sample: n=40 (42 knees) | Intervention: | 1. Standardized Subjective scores |
| Frobell et al | Sample: n=121 | Intervention: | 1. Radiographic |
| Exercise | Retention: 120/121 | 3. Standardized Subjective scores | |
| Neuman et al | Sample: | All treated with exercise program | 1. MRI (dGEMRIC) |
Abbreviations: ACL, anterior cruciate ligament; BMI, body mass index; IKDC, International Knee Documentation Committee; KOOS, Knee injury and Osteoarthritis Outcome Score; OA, osteoarthritis, n, number of participants; M, men; W, women; y, years; mo, months; rng, range; FU, follow-up; I, injury; ns, not significiant; dGEMRIC, delayed gadolinium-enhanced magnetic resonance imaging of cartilage; MRI, magnetic resonance imaging.
Exercise intervention description in the included studies
| Author (year) | Exercise intervention |
|---|---|
| Giove et al | Muscle rehabilitation program targeting the quadriceps and hamstrings, including: isometric, isotonic and isokinetic exercises (at least 7 months) |
| Hawkins et al | Physiotherapist supervised exercise program targeting the quadriceps and hamstrings |
| Kannus and Jarvinen | Initial immobilization; isometric quadriceps exercises; rehabilitation (at least 6 months) |
| Pattee et al | Exercise/rehabilitation program targeting the quadriceps and hamstrings (supervised 3–6 weeks; encouraged to continue) |
| Daniel et al | Initial immobilization; home exercise of cycling, swimming, isotonic exercises targeting the hamstrings |
| Fink et al | Home exercise program of cycling, swimming and strengthening exercises targeting the hamstrings |
| Fithian et al | Initial range of motion and nonimpact closed chain strengthening; jogging and sport-specific exercise (6–12 weeks after injury); return to competitive sports (3 months after injury, if not symptomatic) |
| Meunier et al | Rehabilitation program targeting strength and coordination |
| Kessler et al | Rehabilitation program including: bracing (6 weeks), quadriceps and hamstring muscle exercises, proprioception exercises, no loaded flexion greater than 60° (6 weeks), return to sports (3 months, if not symptomatic), return to contact/pivoting sports (9 months, if not symptomatic) |
| Kostogiannis et al | Either physiotherapist supervised neuromuscular training or self-monitored training; both programs targeted stability and mobility, strength, performance, muscle activation strategies, proprioception and postural control |
| Meuffels et al | Swelling reduction and range of motion; quadriceps and hamstrings strengthening program (at least 3 months) |
| Mihelic et al | Initial immobilization; rehabilitation program including: range of motion, quadriceps strengthening (2 months); activity modification |
| Streich et al | Physiotherapist supervised neuromuscular based rehabilitation program targeting stability and mobility; closed chain kinetic exercises, activity level progression |
| Potter et al | Standard rehabilitation program |
| Frobell et al | Rehabilitation program consistent with literature consensus |
PRISMA 2009 checklist
| Section/topic | Number | Checklist item | Reported on page number |
|---|---|---|---|
| Title | 1 | Identify the report as a systematic review, meta-analysis, or both | 1 |
| Structured summary | 2 | Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number | 1 |
| Rationale | 3 | Describe the rationale for the review in the context of what is already known | 1,2 |
| Objectives | 4 | Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS) | 2 |
| Protocol and registration | 5 | Indicate if a review protocol exists, if and where it can be accessed (eg, web address), and, if available, provide registration information including registration number | N/A |
| Eligibility criteria | 6 | Specify study characteristics (eg, PICOS, length of follow-up) and report characteristics (eg, years considered, language, publication status) used as criteria for eligibility, giving rationale | 2,3 |
| Information sources | 7 | Describe all information sources (eg, databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched | 2 |
| Search | 8 | Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated | |
| Study selection | 9 | State the process for selecting studies (ie, screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis) | 2 |
| Data collection process | 10 | Describe method of data extraction from reports (eg, piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators | 2 |
| Data items | 11 | List and define all variables for which data were sought (eg, PICOS, funding sources) and any assumptions and simplifications made | 2,3 |
| Risk of bias in individual studies | 12 | Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis | 3 |
| Summary measures | 13 | State the principal summary measures (eg, risk ratio, difference in means) | 3 |
| Synthesis of results | 14 | Describe the methods of handling data and combining results of studies, if done, including measures of consistency (eg, I2) for each meta-analysis | N/A |
| Risk of bias across studies | 15 | Specify any assessment of risk of bias that may affect the cumulative evidence (eg, publication bias, selective reporting within studies) | N/A |
| Additional analyses | 16 | Describe methods of additional analyses (eg, sensitivity or subgroup analyses, meta-regression), if done, indicating which were prespecified | N/A |
| Study selection | 17 | Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram | 3 |
| Study characteristics | 18 | For each study, present characteristics for which data were extracted (eg, study size, PICOS, follow-up period) and provide the citations | |
| Risk of bias within studies | 19 | Present data on risk of bias of each study and, if available, any outcome-level assessment (Item 12) | 11, |
| Results of individual studies | 20 | For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group and (b) effect estimates and confidence intervals, ideally with a forest plot | |
| Synthesis of results | 21 | Present results of each meta-analysis done, including confidence intervals and measures of consistency | N/A |
| Risk of bias across studies | 22 | Present results of any assessment of risk of bias across studies (Item 15) | 13–15 |
| Additional analysis | 23 | Give results of additional analyses, if done (eg, sensitivity or subgroup analyses, meta-regression [Item 16]) | N/A |
| Summary of evidence | 24 | Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (eg, health care providers, users, and policy makers) | 12,13 |
| Limitations | 25 | Discuss limitations at study and outcome level (eg, risk of bias), and at review level (eg, incomplete retrieval of identified research, reporting bias) | 13–15 |
| Conclusion | 26 | Provide a general interpretation of the results in the context of other evidence, and implications for future research | 15 |
| Funding | 27 | Describe sources of funding for the systematic review and other support (eg, supply of data); role of funders for the systematic review | N/A |
Note: Reproduced from Moher D, Liberati A, Tetzlaff J, Altman DG; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–249.31
Abbreviations: N/A, not applicable; PRISMA, Preferred Reporting Items for Systematic reviews and Meta-Analyses.